THOUSAND OAKS, Calif., Oct. 28, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2020. Key results include: Total revenues increased 12% to $6.4 billion in comparison to the third quarter of 2019 driven by higher volume growth, partially offset by lower net selling prices and the effects of […]
Financial
Teleflex Announces Quarterly Dividend
WAYNE, Pa., Oct. 29, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable December 15, 2020 to shareholders of record at the close of business on […]
Abiomed Announces Q2 FY 2021 Revenue of $210 Million, Up 27% Over Q1 FY 2021 and Up 2% Over Q2 FY 2020 With 29.2% Operating Margin
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart support technologies today reported second quarter fiscal 2021 revenue of $209.8 million, a sequential increase of 27% compared to Q1 fiscal year 2021 and a year over year increase of 2% compared to Q2 fiscal year 2020 despite […]
LivaNova Reports Third Quarter 2020 Results
Company announces Chief Financial Officer transition LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2020. For the third quarter of 2020, worldwide sales from continuing operations were $240.1 million, a decrease of 10.6 percent on a reported […]
BioSig Issues October 2020 Shareholder Update Letter
Westport, CT, Oct. 28, 2020 (GLOBE NEWSWIRE) — Company’s PURE EP™ System’s data-driven commercialization is gaining acceptance through new evaluative installations at medical centers of excellence The strongest cash balance in its history positions the Company well to execute on its strategic goals. BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or […]
Bayer Signs Letter of Intent to Build New Distribution Center in Saxonburg, PA
New 220,000 square-foot Distribution Center to support ongoing growth of business PITTSBURGH–(BUSINESS WIRE)–Bayer announced its plans to build a new 220,000 sq. ft. Distribution Center to support the ongoing growth of Bayer’s Radiology global business that supplies medical device products world-wide. A 10-year lease with optional extensions is being negotiated. […]
Corventive Health Partners with Halfpenny Technologies to Enhance its Cardiac Care Solutions
NEWTOWN, Pa., Oct. 26, 2020 /PRNewswire/ — Corventive Health, a provider of cloud-based and AI technology solutions, announced a partnership with Halfpenny Technologies, an Accumen, Inc. company today. This partnership fortifies Corventive’s core capability of delivering clinical insights that improve care coordination and cardiac outcomes. Corventive provides early cardiovascular disease detection and intervention […]
Titan Medical Announces Achievement of $10 Million Technical Milestone Under Medtronic Development and License Agreement
TORONTO–(BUSINESS WIRE)–Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has completed the first technical milestone under the development and license agreement with Medtronic plc (“Medtronic”) […]
Zynex Appoints Neil Friery as President and Chief Operating Officer of Monitoring Solutions Division
ENGLEWOOD, Colo., Oct. 23, 2020 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced that it has hired Neil Friery as the President and Chief Operating Officer (COO) of its Monitoring Solutions Division. As […]
Milestone Pharmaceuticals Announces Pricing of a Public Offering of $45 Million of Common Shares and Pre-Funded Warrants
MONTREAL and CHARLOTTE, N.C., Oct. 23, 2020 /PRNewswire/ — Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications, today announced the pricing of its previously announced underwritten public offering of 3,810,097 of its common shares, and to certain investors in lieu […]



